1
|
Mareczek L, Riehl C, Harms M, Reichl S. Analysis of the impact of material properties on tabletability by principal component analysis and partial least squares regression. Eur J Pharm Sci 2024; 200:106836. [PMID: 38901784 DOI: 10.1016/j.ejps.2024.106836] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2024] [Revised: 05/27/2024] [Accepted: 06/17/2024] [Indexed: 06/22/2024]
Abstract
Principal component analysis (PCA) and partial least squares regression (PLS) were combined in this study to identify key material descriptors determining tabletability in direct compression and roller compaction. An extensive material library including 119 material descriptors and tablet tensile strengths of 44 powders and roller compacted materials with varying drug loads was generated to systematically elucidate the impact of different material descriptors, raw API and filler properties as well as process route on tabletability. A PCA model was created which highlighted correlations between different powder descriptors and respective characterization methods and, thus, can enable reduction of analyses to save resources to a certain extent. Subsequently, PLS models were established to identify key material attributes for tabletability such as density and particle size but also surface energy, work of cohesion and wall friction, which were for the first time demonstrated by PLS as highly relevant for tabletability in roller compaction and direct compression. Further, PLS based on extensive material characterization enabled the prediction of tabletability of materials unknown to the model. Thus, this study highlighted how PCA and PLS are useful tools to elucidate the correlations between powder and tabletability, which will enable more robust prediction of manufacturability in formulation development.
Collapse
Affiliation(s)
- Lena Mareczek
- Institute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Braunschweig 38106, Germany; Department of Orals Development, Merck Healthcare KGaA, Darmstadt 64293, Germany
| | - Carolin Riehl
- Department of Orals Development, Merck Healthcare KGaA, Darmstadt 64293, Germany.
| | - Meike Harms
- Department of Orals Development, Merck Healthcare KGaA, Darmstadt 64293, Germany
| | - Stephan Reichl
- Institute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Braunschweig 38106, Germany.
| |
Collapse
|
2
|
Yaginuma K, Matsunami K, Descamps L, Ryckaert A, De Beer T. Hybrid modeling of T-shaped partial least squares regression and transfer learning for formulation and manufacturing process development of new drug products. Int J Pharm 2024; 662:124463. [PMID: 39009287 DOI: 10.1016/j.ijpharm.2024.124463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2024] [Revised: 07/09/2024] [Accepted: 07/10/2024] [Indexed: 07/17/2024]
Abstract
T-shaped partial least squares regression (T-PLSR) is a valuable machine learning technique for the formulation and manufacturing process development of new drug products. An accurate T-PLSR model requires experimental data with multiple formulations and process conditions. However, it is usually challenging to collect comprehensive experimental data using large-scale manufacturing equipment because of the cost, time, and large consumption of raw materials. This study proposes a hybrid modeling of T-PLSR and transfer learning (TL) to enhance the prediction performance of a T-PLSR model for large-scale manufacturing data by exploiting a large amount of small-scale manufacturing data for model building. The proposed method of T-PLSR+TL was applied to a practical case study focusing on scaling up the tableting process from an experienced compaction simulator to a less-experienced rotary tablet press. The T-PLSR+TL models achieved significantly better prediction performance for tablet quality attributes of new drug products than T-PLSR models without using large-scale manufacturing data with new drug products. The results demonstrated that T-PLSR+TL is more capable of addressing new drug products than T-PLSR by using small-scale manufacturing data to cover a scarcity of large-scale manufacturing data. Furthermore, T-PLSR+TL holds the potential to streamline formulation and manufacturing process development activities for new drug products using an extensive database.
Collapse
Affiliation(s)
- Keita Yaginuma
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium.
| | - Kensaku Matsunami
- Pharmaceutical Engineering Research Group, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Laure Descamps
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Alexander Ryckaert
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium
| | - Thomas De Beer
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium
| |
Collapse
|
3
|
Bekaert B, Janssen P, Fathollahi S, Vanderroost D, Roelofs T, Dickhoff B, Vervaet C, Vanhoorne V. Batch vs. continuous direct compression - a comparison of material processability and final tablet quality. Int J Pharm X 2024; 7:100226. [PMID: 38235316 PMCID: PMC10792456 DOI: 10.1016/j.ijpx.2023.100226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 12/06/2023] [Accepted: 12/18/2023] [Indexed: 01/19/2024] Open
Abstract
In this study, an in-depth comparison was made between batch and continuous direct compression using similar compression set-ups. The overall material processability and final tablet quality were compared and evaluated. Correlations between material properties, process parameters and final tablet properties were made via multivariate data analyses. In total, 10 low-dosed (1% w/w) and 10 high-dosed (40% w/w) formulations were processed, using a total of 10 different fillers/filler combinations. The trials indicated that the impact of filler type, drug load or process settings was similar for batch and continuous direct compression. The main differentiator between batch and continuous was the flow dynamics in the operating system, where properties related to flow, compressibility and permeability played a crucial role. The less consistent flow throughout a batch process resulted in a significantly higher variability within the tablet press (σCF) and for the tablet quality responses (σMass, σTS). However, the better controlled blending procedure prior to batch processing was reflected in a more consistent API concentration variability. Overall, the comparison showed the benefits of selecting appropriate excipients and process settings to achieve a specific outcome, keeping in mind some key differentiators between both processes.
Collapse
Affiliation(s)
- B. Bekaert
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| | - P.H.M. Janssen
- Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, the Netherlands
- DFE Pharma, Klever Strasse 187, 47568 Goch, Germany
| | | | - D. Vanderroost
- GEA Process Engineering, Keerbaan 70, B-2160 Wommelgem, Belgium
| | - T. Roelofs
- DFE Pharma, Klever Strasse 187, 47568 Goch, Germany
| | | | - C. Vervaet
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| | - V. Vanhoorne
- Laboratory of Pharmaceutical Technology, Department of Pharmaceutics, Ghent University, Ottergemsesteenweg 460, B-9000 Ghent, Belgium
| |
Collapse
|
4
|
Cao J, Shen H, Zhao S, Ma X, Chen L, Dai S, Xu B, Qiao Y. Sample Size Requirements of a Pharmaceutical Material Library: A Case in Predicting Direct Compression Tablet Tensile Strength by Latent Variable Modeling. Pharmaceutics 2024; 16:242. [PMID: 38399296 PMCID: PMC10893091 DOI: 10.3390/pharmaceutics16020242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2023] [Revised: 01/26/2024] [Accepted: 01/31/2024] [Indexed: 02/25/2024] Open
Abstract
The material library is an emerging, new data-driven approach for developing pharmaceutical process models. How many materials or samples should be involved in a particular application scenario is unclear, and the impact of sample size on process modeling is worth discussing. In this work, the direct compression process was taken as the research object, and the effects of different sample sizes of material libraries on partial least squares (PLS) modeling in the prediction of tablet tensile strength were investigated. A primary material library comprising 45 materials was built. Then, material subsets containing 5 × i (i = 1, 2, 3, …, 8) materials were sampled from the primary material library. Each subset underwent sampling 1000 times to analyze variations in model fitting performance. Both hierarchical sampling and random sampling were employed and compared, with hierarchical sampling implemented with the help of the tabletability classification index d. For each subset, modeling data were organized, incorporating 18 physical properties and tableting pressure as the independent variables and tablet tensile strength as the dependent variable. A series of chemometric indicators was used to assess model performance and find important materials for model training. It was found that the minimum R2 and RMSE values reached their maximum, and the corresponding values were kept almost unchanged when the sample sizes varied from 20 to 45. When the sample size was smaller than 15, the hierarchical sampling method was more reliable in avoiding low-quality few-shot PLS models than the random sampling method. Two important materials were identified as useful for building an initial material library. Overall, this work demonstrated that as the number of materials increased, the model's reliability improved. It also highlighted the potential for effective few-shot modeling on a small material library by controlling its information richness.
Collapse
Affiliation(s)
- Junjie Cao
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Haoran Shen
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
| | - Shuying Zhao
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Xiao Ma
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Liping Chen
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Shengyun Dai
- National Institutes for Food and Drug Control, Beijing 100050, China;
| | - Bing Xu
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| | - Yanjiang Qiao
- Department of Chinese Medicine Informatics, School of Chinese Materia Medica, Beijing University of Chinese Medicine, No. 11, North Third Ring East Road, Beijing 100029, China; (J.C.); (H.S.); (S.Z.); (X.M.); (L.C.)
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, China
| |
Collapse
|
5
|
Su J, Zhang K, Qi F, Cao J, Miao Y, Zhang Z, Qiao Y, Xu B. A tabletability change classification system in supporting the tablet formulation design via the roll compaction and dry granulation process. Int J Pharm X 2023; 6:100204. [PMID: 37560487 PMCID: PMC10407897 DOI: 10.1016/j.ijpx.2023.100204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Revised: 07/26/2023] [Accepted: 07/27/2023] [Indexed: 08/11/2023] Open
Abstract
In this paper, the material library approach was used to uncover the pattern of tabletability change and related risk for tablet formulation design under the roll compaction and dry granulation (RCDG) process. 31 materials were fully characterized using 18 physical parameters and 9 compression behavior classification system (CBCS) parameters. Then, each material was dry granulated and sieved into small granules (125-250 μm) and large granules (630-850 μm), respectively. The compression behavior of granules was characterized by the CBCS descriptors, and were compared with that of ungranulated powders. The relative change of tabletability (CoTr) index was used to establish the tabletability change classification system (TCCS), and all materials were classified into three types, i.e. loss of tabletability (LoT, Type I), unchanged tabletability (Type II) and increase of tabletability (Type III). Results showed that approximately 65% of materials presented LoT, and as the granules size increased, 84% of the materials exhibited LoT. A risk decision tree was innovatively proposed by joint application of the CBCS tabletability categories and the TCCS tabletability change types. It was found that the LoT posed little risk to the tensile strength of the final tablet, when Category 1 or 2A materials, or Category 2B materials with Type II or Type III change of tabletability were used. Formulation risk happened to Category 2C or 3 materials, or Category 2B materials with Type I change of tabletability, particularly when high proportions of these materials were involved in tablet formulation. In addition, the risk assessment results were verified in the material property design space developed from a latent variable model in prediction of tablet tensile strength. Overall, results suggested that a combinational use of CBCS and TCCS could aid the decision making in selecting materials for tablet formulation design via RCDG.
Collapse
Affiliation(s)
- Junhui Su
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| | - Kunfeng Zhang
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Feiyu Qi
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Junjie Cao
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
| | - Yuhua Miao
- The International Department, No. 8 Middle School of Beijing, Beijing 100045, PR China
| | - Zhiqiang Zhang
- Beijing Tcmages Pharmceutical Co. LTD, Beijing 101301, PR China
| | - Yanjiang Qiao
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| | - Bing Xu
- Department of Chinese Medicine Informatics, Beijing University of Chinese Medicine, Beijing 100029, PR China
- Beijing Key Laboratory of Chinese Medicine Manufacturing Process Control and Quality Evaluation, Beijing 100029, PR China
| |
Collapse
|
6
|
Matsunami K, Meyer J, Rowland M, Dawson N, De Beer T, Van Hauwermeiren D. T-shaped partial least squares for high-dosed new active pharmaceutical ingredients in continuous twin-screw wet granulation: Granule size prediction with limited material information. Int J Pharm 2023; 646:123481. [PMID: 37805145 DOI: 10.1016/j.ijpharm.2023.123481] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Revised: 10/02/2023] [Accepted: 10/03/2023] [Indexed: 10/09/2023]
Abstract
This work presents a granule size prediction approach applicable to diverse formulations containing new active pharmaceutical ingredients (APIs) in continuous twin-screw wet granulation. The approach consists of a surrogate selection method to identify similar materials with new APIs and a T-shaped partial least squares (T-PLS) model for granule size prediction across varying formulations and process conditions. We devised a surrogate material selection method, employing a combination of linear pre-processing and nonlinear classification algorithms, which effectively identified suitable surrogates for new materials. Using only material properties obtained through four characterization methods, our approach demonstrated its predictive prowess. The selected surrogate methods were seamlessly integrated with our developed T-PLS model, which was meticulously validated for high-dose formulations involving three new APIs. When surrogating new APIs based on Gaussian process classification, we achieved the lowest prediction errors, signifying the method's robustness. The predicted d-values were within the range of uncertainty bounds for all cases, except for d90 of API C. Notably, the approach offers a direct and efficient solution for early-phase formulation and process development, considerably reducing the need for extensive experimental work. By relying on just four material characterization methods, it streamlines the research process while maintaining a high degree of accuracy.
Collapse
Affiliation(s)
- Kensaku Matsunami
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium; BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, Ghent, 9000, Oost-Vlaanderen, Belgium.
| | - Jonathan Meyer
- Worldwide Research and Development, Pfizer Inc., Sandwich, Kent, UK
| | - Martin Rowland
- Worldwide Research and Development, Pfizer Inc., Sandwich, Kent, UK
| | - Neil Dawson
- Worldwide Research and Development, Pfizer Inc., Sandwich, Kent, UK
| | - Thomas De Beer
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium
| | - Daan Van Hauwermeiren
- Laboratory of Pharmaceutical Process Analytical Technology, Department of Pharmaceutical Analysis, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Oost-Vlaanderen, Belgium; BIOMATH, Department of Data Analysis and Mathematical Modelling, Ghent University, Coupure links 653, Ghent, 9000, Oost-Vlaanderen, Belgium
| |
Collapse
|
7
|
Sousa AS, Serra J, Estevens C, Costa R, Ribeiro AJ. Leveraging a multivariate approach towards enhanced development of direct compression extended release tablets. Int J Pharm 2023; 646:123432. [PMID: 37739095 DOI: 10.1016/j.ijpharm.2023.123432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 09/16/2023] [Accepted: 09/19/2023] [Indexed: 09/24/2023]
Abstract
Extended release formulations play a crucial role in the pharmaceutical industry by maintaining steady plasma levels, reducing side effects, and improving therapeutic efficiency and compliance. One commonly used method to develop extended release formulations is direct compression, which offers several advantages, such as simplicity, time savings, and cost-effectiveness. However, successful direct compression-based extended release formulations require careful assessment and an understanding of the excipients' attributes. The scope of this work is the characterization of the compaction behavior of some matrix-forming agents and diluents for the development of extended release tablets. Fifteen excipients commonly used in extended release formulations were evaluated for physical, compaction and tablet properties. Powder properties (e.g., particle size, flow properties, bulk density) were evaluated and linked to the tablet's mechanical properties in a fully integrated approach, and data were analyzed by constructing a principal component analysis (PCA). Significant variability was observed among the various excipients. The present work successfully demonstrates the applicability of PCA as an effective tool for comparative analysis, pattern and clustering recognition and correlations between excipients and their properties, facilitating the development and manufacturing of direct compressible extended release formulations.
Collapse
Affiliation(s)
- A S Sousa
- Universidade de Coimbra, Faculdade de Farmácia, 3000-148 Coimbra, Portugal; Grupo Tecnimede, Quinta da Cerca, Caixaria, 2565-187 Dois Portos, Portugal
| | - J Serra
- Grupo Tecnimede, Quinta da Cerca, Caixaria, 2565-187 Dois Portos, Portugal
| | - C Estevens
- Grupo Tecnimede, Quinta da Cerca, Caixaria, 2565-187 Dois Portos, Portugal
| | - R Costa
- Grupo Tecnimede, Quinta da Cerca, Caixaria, 2565-187 Dois Portos, Portugal
| | - A J Ribeiro
- Universidade de Coimbra, Faculdade de Farmácia, 3000-148 Coimbra, Portugal; i3S, IBMC, Rua Alfredo Allen, 4200-135 Porto, Portugal.
| |
Collapse
|
8
|
Shi C, Zhao H, Fang Y, Shen L, Zhao L. Lactose in tablets: Functionality, critical material attributes, applications, modifications and co-processed excipients. Drug Discov Today 2023; 28:103696. [PMID: 37419210 DOI: 10.1016/j.drudis.2023.103696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Revised: 06/06/2023] [Accepted: 06/29/2023] [Indexed: 07/09/2023]
Abstract
Lactose is one of the most widespread excipients used in the pharmaceutical industry. Because of its water solubility and acceptable flowability, lactose is generally added into tablet formulation to improve wettability and undesirable flowability. Based on Quality by Design, a better understanding of the critical material attributes (CMAs) of raw materials is beneficial in guiding the improvement of tablet quality and the development of lactose. Additionally, the modifications and co-processing of lactose can introduce more-desirable characteristics to the resulting particles. This review focuses on the functionality, CMAs, applications, modifications and co-processing of lactose in tablets.
Collapse
Affiliation(s)
- Chuting Shi
- Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine of Ministry of Education, Shanghai University of Traditional Chinese Medicine, No. 1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China
| | - Haiyue Zhao
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, No. 1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China
| | - Ying Fang
- Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine of Ministry of Education, Shanghai University of Traditional Chinese Medicine, No. 1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China
| | - Lan Shen
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, No. 1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China.
| | - Lijie Zhao
- Engineering Research Center of Modern Preparation Technology of Traditional Chinese Medicine of Ministry of Education, Shanghai University of Traditional Chinese Medicine, No. 1200, Cai-lun Road, Pudong District, Shanghai 201203, PR China.
| |
Collapse
|
9
|
Using a Material Library to Understand the Change of Tabletability by High Shear Wet Granulation. Pharmaceutics 2022; 14:pharmaceutics14122631. [PMID: 36559125 PMCID: PMC9783360 DOI: 10.3390/pharmaceutics14122631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Revised: 11/16/2022] [Accepted: 11/23/2022] [Indexed: 11/29/2022] Open
Abstract
Understanding the tabletability change of materials after granulation is critical for the formulation and process design in tablet development. In this paper, a material library consisting of 30 pharmaceutical materials was used to summarize the pattern of change of tabletability during high shear wet granulation and tableting (HSWGT). Each powdered material and the corresponding granules were characterized by 19 physical properties and nine compression behavior classification system (CBCS) parameters. Principal component analysis (PCA) was used to compare the physical properties and compression behaviors of ungranulated powders and granules. A new index, namely the relative change of tabletability (CoTr), was proposed to quantify the tabletability change, and its advantages over the reworking potential were demonstrated. On the basis of CoTr values, the tabletability change classification system (TCCS) was established. It was found that approximately 40% of materials in the material library presented a loss of tabletability (i.e., Type I), 50% of materials had nearly unchanged tabletability (i.e., Type II), and 10% of materials suffered from increased tabletability (i.e., Type III). With the help of tensile strength (TS) vs. compression pressure curves implemented on both powders and granules, a data fusion method and the PLS2 algorithm were further applied to identify the differences in material properties requirements for direct compression (DC) and HSWGT. Results indicated that increasing the plasticity or porosity of the starting materials was beneficial to acquiring high TS of tablets made by HSWGT. In conclusion, the presented TCCS provided a means for the initial risk assessment of materials in tablet formulation design and the data modeling method helped to predict the impact of formulation ingredients on the strength of compacts.
Collapse
|
10
|
Naranjo Gómez LN, De Beer T, Kumar A. Finite Element Modeling of Powder Compaction: Mini-Tablets in Comparison with Conventionally Sized Tablets. Pharm Res 2022; 39:2109-2118. [PMID: 36192615 DOI: 10.1007/s11095-022-03389-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 09/01/2022] [Indexed: 06/16/2023]
Abstract
INTRODUCTION Mini-tablets are considered a promising solid dosage form in the pharmaceutical industry due to advantages such as dosing accuracy, efficiency as a drug delivery system, and alleged improvement in mechanical properties. Nevertheless, only a few experimental studies are available in the literature regarding this topic and technical aspects, such as punch's shape and size effect on the stress and density distribution in the compact mini-tablets, are still not fully investigated. OBJECTIVES In this paper, the influence of powder properties and process parameters, such as punch shape and size, on the evolution of mechanical properties during the tableting process and the potential occurrence of tablet defects are investigated using the mechanistic modeling approach, Finite Element Method (FEM). METHODS The numerical simulation cases consist of four different die sizes, mini-tablets of 2 mm, and 3 mm, and conventionally sized tablets of 8 mm and 11.28 mm. Each tablet size is simulated using four distinctive excipients, Avicel® PH-102, Kollidon® VA64, Pearlitol® 100SD, and Supertab® 11SD, and two different punch geometries, a flat-face punch, and a bevel edge punch. RESULTS The model predictions in terms of stress and density distribution at different stages of the compaction process indicate similar behavior in terms of density and stress distribution profiles between the conventionally sized tablets and mini-tablets for a particular excipient. CONCLUSIONS Based on tablet size, small localized differences are noted (e.g., low-density regions, high shear bands, and heterogeneous density profiles), suggesting a possible risk of tableting defects for conventionally sized tablets compared to mini-tablets. Furthermore, it is observed that bevel-edged tablets could facilitate the formation of cracks, leading to possible capping failure.
Collapse
Affiliation(s)
- Luz Nadiezda Naranjo Gómez
- Pharmaceutical Engineering Research Group (PharmaEng), Department of Pharmaceutical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium
- Laboratory of Pharmaceutical Process Analytical Technology (LPPAT), Department of Pharmaceutical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium
| | - Thomas De Beer
- Laboratory of Pharmaceutical Process Analytical Technology (LPPAT), Department of Pharmaceutical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium
| | - Ashish Kumar
- Pharmaceutical Engineering Research Group (PharmaEng), Department of Pharmaceutical Analysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium.
| |
Collapse
|